P

Inventor

FREI JOERG

CH29 patents
⚠️ This page may combine multiple inventors who share the name “FREI JOERG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CIBA GEIGY CORP

15 patents

NOVARTIS AG

13 patents
US6258812B1Jul 10, 2001

Phthalazines with angiogenesis inhibiting activity

NOVARTIS AG206 citations98
US5981533ANov 9, 1999

Pyrazole derivatives and processes for the preparation thereof

NOVARTIS AG104 citations98
US6140332AOct 31, 2000

Pyrrolopyrimidines and processes for the preparation thereof

NOVARTIS AG214 citations97
US6251911B1Jun 26, 2001

Pyrimidine derivatives and processes for the preparation thereof

NOVARTIS AG64 citations96
US6180636B1Jan 30, 2001

Substituted pyrrolopyrimidines and processes for their preparation

NOVARTIS AG78 citations96
US6710047B2Mar 23, 2004

Phthalazines with angiogenesis inhibiting activity

NOVARTIS AG25 citations92
US6514974B2Feb 4, 2003

Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity

NOVARTIS AG15 citations92
US6140317AOct 31, 2000

Pyrrolopyrimidines and processes for their preparation

NOVARTIS AG37 citations92
US6686347B2Feb 3, 2004

Phthalazine derivatives for treating inflammatory diseases

NOVARTIS AG18 citations90
US5840911ANov 24, 1998

Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors

NOVARTIS AG16 citations74
US5834486ANov 10, 1998

Piperidinyl-2-alkyl, substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation

NOVARTIS AG0 citations52
US6911440B2Jun 28, 2005

Phthalazine derivatives for treating inflammatory diseases

NOVARTIS AG1 citations50
US7329660B2Feb 12, 2008

Phthalazine derivatives for treating inflammatory diseases

NOVARTIS AG1 citations46

(unassigned)

1 patent